Prosecution Insights
Last updated: August 17, 2026

Mallinckrodt Pharmaceuticals Ireland Limited

12 pending office actions • 5 art units • 10 examiners • 0 of 12 (0%) have an AI response strategy ready • 15 patents granted in the last 365 days

Portfolio Summary

12
Total Pending OAs
5
Non-Final OAs
7
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

5
Hard (42%)
7
Medium (58%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only6 (50%)
Double-patenting + other1 (8%)
Multi-statute (no §101)5 (42%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

4
Life Sciences
33% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
7
Mechanical / Eng
58% of docket
1
Business / Other
8% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

120 h
Manual time on pending OAs
24 h
Time saved (low, 20%)
42 h
Time saved (mid, 35%)
1.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LEE, JIA-HAI 2 49.8% +48.0%
ZHANG, TINA 2 56.5% +44.3%
WEN, SHARON X 1 56.8% +32.8%
TRINH, HONG-VAN N 1 62.4% +58.8%
PALENIK, JEFFREY T 1 53.8% +26.8%
WRIGHT, AMIRAH DANNYE 1
FREDRICKSON, COURTNEY B 1 75.7% +30.9%
SIPPEL, RACHEL T 1 52.2% +58.1%
DIXON, ANNETTE FREDRICKA 1 74.4% +26.0%
HOWELL, GWYNNETH LINNEA 1 42.0% +80.7%

Hard Cases (5)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
19213363 COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME WEN, SHARON X 19d overdue
18109510 SYSTEMS AND METHODS FOR DELIVERY OF THERAPEUTIC GAS ZHANG, TINA 3d overdue
18441216 SAMPLE GAS FILTER FOR A THERAPEUTIC GAS DELIVERY DEVICE WRIGHT, AMIRAH DANNYE
18480264 PRE-FILLED MANUAL INJECTOR APPARATUS FREDRICKSON, COURTNEY B
17421803 COMBINATION DRUG THERAPIES OF PDE-5 INHIBITORS AND INHALED NITRIC OXIDE HOWELL, GWYNNETH LINNEA

Interview Candidates (11)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18783546 METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 LEE, JIA-HAI 222d overdue
19213363 COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME WEN, SHARON X 19d overdue
19169718 PRE-FILLED MANUAL INJECTOR APPARATUS TRINH, HONG-VAN N 9d overdue
18109510 SYSTEMS AND METHODS FOR DELIVERY OF THERAPEUTIC GAS ZHANG, TINA 3d overdue
18000188 METHOD FOR PULSATILE DELIVERY OF A GASEOUS DRUG DIXON, ANNETTE FREDRICKA 28d
17104864 METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 LEE, JIA-HAI 54d
18726314 USE OF INHALED NITRIC OXIDE (INO) FOR TREATING PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH SARCOIDOSIS (PH-SARC) PALENIK, JEFFREY T
18480264 PRE-FILLED MANUAL INJECTOR APPARATUS FREDRICKSON, COURTNEY B

Top Art Units

Art UnitApps
3785 5
3783 2
1658 2
1641 1
1615 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19213363 COMPOSITIONS FOR IMPROVING KIDNEY FUNCTION IN PATIENTS WITH HEPATORENAL SYNDROME WEN, SHARON X 1641 §102§103Other Final Rejection 19d overdue Pending May 20, 2025
19169718 PRE-FILLED MANUAL INJECTOR APPARATUS TRINH, HONG-VAN N 3783 §103 Final Rejection 9d overdue Pending Apr 03, 2025
18783546 METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 LEE, JIA-HAI 1658 §103Other Non-Final OA 222d overdue Pending Jul 25, 2024
18726314 USE OF INHALED NITRIC OXIDE (INO) FOR TREATING PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH SARCOIDOSIS (PH-SARC) PALENIK, JEFFREY T 1615 §103 Non-Final OA Pending Jul 02, 2024
18441216 SAMPLE GAS FILTER FOR A THERAPEUTIC GAS DELIVERY DEVICE WRIGHT, AMIRAH DANNYE §102§103§112 Non-Final OA Pending Feb 14, 2024
18480264 PRE-FILLED MANUAL INJECTOR APPARATUS FREDRICKSON, COURTNEY B 3783 §103§112 Final Rejection Pending Oct 03, 2023
18117917 SYSTEMS AND METHOD FOR DELIVERY OF THERAPEUTIC GAS TO PATIENTS, IN NEED THEREOF, RECEIVING BREATHING GAS FROM A VENTILATOR THAT VARIES AT LEAST PRESSURE AND/OR FLOW USING ENHANCED THERAPEUTIC GAS (NO) FLOW MEASUREMENT SIPPEL, RACHEL T 3785 §103§112DPOther Non-Final OA Pending Mar 06, 2023
18109510 SYSTEMS AND METHODS FOR DELIVERY OF THERAPEUTIC GAS ZHANG, TINA 3785 §102§103§112 Final Rejection 3d overdue Pending Feb 14, 2023
18000188 METHOD FOR PULSATILE DELIVERY OF A GASEOUS DRUG DIXON, ANNETTE FREDRICKA 3785 §103 Non-Final OA 28d Pending Nov 29, 2022
17421803 COMBINATION DRUG THERAPIES OF PDE-5 INHIBITORS AND INHALED NITRIC OXIDE HOWELL, GWYNNETH LINNEA 3785 §103§112 Final Rejection Pending Jul 09, 2021
17104864 METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 LEE, JIA-HAI 1658 §103Other Final Rejection 54d Pending Nov 25, 2020
17055365 METHOD AND APPARATUS FOR PULSATILE DELIVERY OF NITRIC OXIDE ZHANG, TINA 3785 §103 Final Rejection Pending Nov 13, 2020

Managing Mallinckrodt Pharmaceuticals Ireland Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month